Revision as of 18:49, 17 November 2012 by SylviaStanley(talk | contribs)(→History: Deleted two references that were about NK603 not MON 863. Also deleted "to äll GMOs" Obviously incorrect)
In 2004 Monsanto sought approval in Europe to introduce MON 863. Approval was granted in 2005 for use in feed[1] and in 2006 for use in food.[2] There was controversy over acceptance by regulatory bodies of industry-funded toxicity studies and over the design of those studies led by Pr Gilles Eric Séralini, who was on the committee that reviewed MON863 for the French government,[3]
Following legal action by parties including the Swedish Board of Agriculture and Greenpeace, a Münster appeals court ruled that Monsanto would be forced to publicly reveal its research data.[4]
^Staff (8 August 2005) [http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_feed.pdf concerning the placing on the market, in accordance with Directive 2001/18/EC of the European
Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm] Commission of the European Communities, Offical Journal, Retrieved 17 November 2012
^Staff (13 January 2006) [http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_food.pdf concerning the placing on the market, in accordance with Directive 2001/18/EC of the European
Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm and in 2006 in food] Commission of the European Communities, Offical Journal, Retrieved 17 November 2012
^ ab"The MON863 case - a chronicle of systematic deception"(PDF). Greenpeace. Retrieved 2010-07-22. MON863 is a genetically modified corn that expresses a Bt-toxin. This toxin is a modified version of the delta endotoxin Cry3Bb1 which originates from the microorganism Bacillus thuringiensis. The genetic manipulation is aimed at protecting maize plants against a pest called corn rootworm (Diabrotica spp.). MON863 differs from other Bt-corns already placed on the market (MON810, BT11, Bt176), which produce a modified Cry1Ab toxin conferring resistance to a pest called European corn borer (Ostrinia nubilalis), in that it produces an artificial Cry3Bb1 toxin. In addition to the modified Cry3Bb1 toxin gene MON863 contains an antibiotic resistance marker gene.
^ abDoull, J.; Gaylor, D.; Greim, H.A.; Lovell, D.P.; Lynch, B.; Munro, I.C. (2007). "Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863)". Food and Chemical Toxicology. 45 (11): 2073–85. doi:10.1016/j.fct.2007.08.033. PMID17900781.
^Lorch, Antje (2005-09-30). "EFSA's Opinion on MON863 hybrids"(PDF). ifrik. Greenpeace. Retrieved 2010-07-22. MON863 contains an GM antibiotic resistance gene (nptII) against kanamycin and neomycin.
^"Technical & Safety Information - Focus on MON 863 / YieldGard Rootworm". Monsanto. Retrieved 2010-07-22. Based on these reviews, this maize has been authorized for planting in the United States and Canada since 2003 and is additionally approved for import and food use in many countries around the world, including Japan, Korea, Taiwan, the Philippines, Australia/New Zealand, China, Russia, Singapore, Mexico and the European Union.[dead link]